Trial Profile
A Double-Blind, Randomized, Active Comparator Study of LT-NS001 Versus Naprosyn for Seven Days in Healthy Subjects With Endoscopic Evaluation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Oct 2010
Price :
$35
*
At a glance
- Drugs Naproxen etemesil (Primary) ; Naproxen
- Indications Musculoskeletal pain; Osteoarthritis; Pain; Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Logical Therapeutics
- 20 Nov 2009 Results presented at GASTRO 2009.
- 20 Oct 2009 Results will be presented at the American College of Gastroenterology's (ACG) Annual Scientific Meeting on October 27, 2009, according to a Logical Therapeutics media release.
- 26 May 2009 Results reported in a Medinox media release.